Colin Carpenter has leadership experience in developing and commercializing solutions at the interface of engineering and medicine, focusing primarily on clinical needs in cancer diagnosis and therapy. He has over a decade of engineering research innovation in healthcare AI and medical devices combined with clinical insights gained working alongside clinicians at Stanford, Memorial Sloan-Kettering, and Dartmouth. Colin commercially introduced the first FDA cleared decision-support system for radiation oncology leveraging artificial intelligence. He has over 100 publications in the fields of Cancer Imaging, Cancer Therapy, Computer Vision, and Machine Learning. He is an alumnus of the Stanford Biodesign program, and obtained a Ph.D. in Biomedical Engineering from Dartmouth.